Fennec Pharmaceuticals Revenue, Growth & Competitor Profile

DBA ADHEREX, INC.
DBA FENNEC PHARMACEUTICALS, INC. DBA FENNEC PHARMACEUTICALS

Company Profile & Annual Report for Fennec Pharmaceuticals

Access the complete profile.

Fennec Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	68 Tw Alexander Dr Research Triangle Park, NC 27709

Note: Revenues for privately held companies are statistical evaluations.


Fennec Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Fennec Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Fennec Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Fennec Pharmaceuticals Annual Revenue and Growth Rate

Fennec Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Fennec Pharmaceuticals's revenues are gauged from an analysis of company filings.

Fennec Pharmaceuticals's Income Statement (based on Industry Averages)

Fennec Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Fennec Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
June 8, 2017	7	100%	$8 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Fennec Pharmaceuticals is developing and marketing. Fennec Pharmaceuticals doesn't have any recent trademark applications, indicating Fennec Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FENNEC HEARS HEARING EDUCATION, ACCESS & REIMBURSEMENT SUPPORT Patient advocacy services, namely, promoting public awareness of pharmaceutical discount opportunities for underserved and needy communities by means of public advocacy and business administration of the patient assistance programs of others by enrolling patients in the assistance programs to assist them in saving money on their prescription medications; business administration of patient pharmaceutical reimbursement programs; business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines	06/21/2022
ZOROPRO Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in pediatric patients	01/18/2017
PEDMARK Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in pediatric patients	01/18/2017

See all trademarks and details in the Full Report.

Market Share of Fennec Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Fennec Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Fennec Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TERGUS PHARMA	Durham, NC	100
HUMACYTE GLOBAL	Durham, NC	87
MEDICAGO USA	Durham, NC	67
BRII BIOSCIENCES	Durham, NC	51
FENNEC PHARMACEUTICALS	Research Triangle Park, NC	46
DOVA PHARMACEUTICALS	Durham, NC	42

Future Competition: Fennec Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Fennec Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)